Figure 1.
CONSORT flow diagram of the patient cohort at time of switch, at 6, 12, and 18 months follow-up. VDZ vedolizumab; SC subcutaneous; IV intravenous.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.